Maharashtra, India

Sanjay Kumar Sharma

This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: Piramal Enterprises Limited, Piramal Pharma Limited. Active years: 2019-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sanjay Kumar Sharma. Retrieved from https://idiyas.com/inventor/sanjay-kumar-sharma-r5xrk3ef

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

Average Co-Inventor Count = 4.1

ph-index = 1


Location History:

  • Mumbai, IN (2019)
  • Maharashtra, IN (2021 - 2022)

Company Filing History:


Years Active: 2019-2022

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Sanjay Kumar Sharma: Innovator in SGLT2 Inhibitors

Introduction

Sanjay Kumar Sharma is a notable inventor based in Maharashtra, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of SGLT2 inhibitors. With a total of three patents to his name, Sharma's work is recognized for its industrial feasibility and economic viability.

Latest Patents

Sanjay Kumar Sharma's latest patents include a process for the preparation of SGLT2 inhibitors and intermediates thereof. This invention relates to an industrially feasible and economically viable process for the preparation of SGLT2 inhibitors of formula X in significantly high yield and purity. Another notable patent is for the preparation of Bexagliflozin of formula V, which also emphasizes high yield and purity in its production process.

Career Highlights

Throughout his career, Sharma has worked with prominent companies such as Piramal Enterprises Limited and Piramal Pharma Limited. His experience in these organizations has allowed him to refine his skills and contribute to innovative pharmaceutical solutions.

Collaborations

Sanjay Kumar Sharma has collaborated with talented individuals in his field, including Milind Moreshwar Gharpure and Sandesh Vishwasrao. These collaborations have further enhanced his research and development efforts.

Conclusion

Sanjay Kumar Sharma stands out as an influential inventor in the pharmaceutical industry, particularly in the area of SGLT2 inhibitors. His patents reflect a commitment to innovation and practical applications in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…